Moderna Inc (LTS:0A45)
$ 39.3575 -1.0175 (-2.51%) Market Cap: 15.50 Bil Enterprise Value: 9.98 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 58/100

Moderna Inc at Cowen HealthCare Conference Transcript

Mar 03, 2020 / 04:20PM GMT
StÃ;phane Bancel
Moderna, Inc. - CEO & Director

© -

We'll be making a few forward-looking statements, so you can look at our forward-looking statements on our website or on the SEC website. So as many of you know, we started the company 9 years ago. We believe that messenger RNA could be a new class of medicines. We're very excited with that because we thought if mRNA could be a safe medicine in human, we could have a very large product opportunity making human proteins in humans, we'll be making antibodies and making vital protein in humans that are making vaccines. We thought because mRNA is an information where I feel that this will be a platform, meaning an incredible ability to learn from one product to be other and the ability to have an increased probability of technical success, take the drugs from preclinical models to the clinic to BLA.

Well, so forth, because mRNA is an information molecule, I think, we invested in manufacturing processes, in robotics, in IT early, we should be able to go very fast. And we saw that because mRNA is made in water, it's a cell-free

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot